171 related articles for article (PubMed ID: 12031320)
21. Anti-angiogenic activity of the purine analog 6-thioguanine.
Presta M; Belleri M; Vacca A; Ribatti D
Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
[TBL] [Abstract][Full Text] [Related]
22. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
Turk BE; Su Z; Liu JO
Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenic activities of Cnidium officinale Makino and Tabanus bovinus.
Kwak DH; Kim JK; Kim JY; Jeong HY; Keum KS; Han SH; Rho YI; Woo WH; Jung KY; Choi BK; Choo YK
J Ethnopharmacol; 2002 Aug; 81(3):373-9. PubMed ID: 12127239
[TBL] [Abstract][Full Text] [Related]
24. Concise stereocontrolled routes to fumagillol, fumagillin, and TNP-470.
Vosburg DA; Weiler S; Sorensen EJ
Chirality; 2003 Feb; 15(2):156-66. PubMed ID: 12520508
[TBL] [Abstract][Full Text] [Related]
25. [Antiangiogenic treatment of cancer].
Mauriz JL; Linares P; González P; Culebras JM
Cir Esp; 2005 Jul; 78(1):3-11. PubMed ID: 16420784
[TBL] [Abstract][Full Text] [Related]
26. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of 9-(4-thio-beta-D-ribo-pentofuranosyl)guanine on tumor growth and angiogenesis.
Miura S; Yamada K; Kano F; Yoshimura Y
Biol Pharm Bull; 2004 Apr; 27(4):520-3. PubMed ID: 15056858
[TBL] [Abstract][Full Text] [Related]
28. Chemical genomics-based target identification and validation of anti-angiogenic agents.
Kwon HJ
Curr Med Chem; 2003 May; 10(9):717-36. PubMed ID: 12678774
[TBL] [Abstract][Full Text] [Related]
29. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2.
Ribatti D; Nico B; Belloni AS; Vacca A; Roncali L; Nussdorfer GG
Int J Mol Med; 2001 Sep; 8(3):265-8. PubMed ID: 11494053
[TBL] [Abstract][Full Text] [Related]
31. TNP-470: an angiogenesis inhibitor in clinical development for cancer.
Kruger EA; Figg WD
Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750
[TBL] [Abstract][Full Text] [Related]
32. [On chance discovery in rational drug design. Aspergillus fumigatus and angiogenesis].
Klein C
Pharm Unserer Zeit; 2007; 36(6):450-1. PubMed ID: 17957690
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells.
Yatsunami J; Aoki S; Fukuno Y; Kikuchi Y; Kawashima M; Hayashi SI
Int J Oncol; 2000 Dec; 17(6):1151-6. PubMed ID: 11078800
[TBL] [Abstract][Full Text] [Related]
34. Methionine aminopeptidase‑2 is a pivotal regulator of vasculogenic mimicry.
Shimizu S; Kawahara R; Simizu S
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34913067
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of anti-angiogenic tyrosine kinase inhibition on wound healing--the obvious and not so obvious.
McCarty ME; Ellis LM
Cancer Biol Ther; 2002; 1(2):127-9. PubMed ID: 12212612
[No Abstract] [Full Text] [Related]
36. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
Castronovo V; Belotti D
Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
[No Abstract] [Full Text] [Related]
37. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.
Ingber D; Fujita T; Kishimoto S; Sudo K; Kanamaru T; Brem H; Folkman J
Nature; 1990 Dec; 348(6301):555-7. PubMed ID: 1701033
[TBL] [Abstract][Full Text] [Related]
38. [Tumor necrotic factor as an inhibitor of angiogenesis].
Sopotsinskaia EB; Lisniak IA
Patol Fiziol Eksp Ter; 1988; (5):62-4. PubMed ID: 2464155
[No Abstract] [Full Text] [Related]
39. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
[TBL] [Abstract][Full Text] [Related]
40. The preclinical evaluation of angiogenesis inhibitors.
O'Reilly MS
Invest New Drugs; 1997; 15(1):5-13. PubMed ID: 9195285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
